Mainz Biomed B.V. Profile Avatar - Palmy Investing

Mainz Biomed B.V.

Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product ca…

Medical - Diagnostics & Research
DE, Mainz [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of MYNZ's Analysis
CIK: 1874252 CUSIP: N5436L101 ISIN: NL0015000LC2 LEI: - UEI: -
Secondary Listings
MYNZ has no secondary listings inside our databases.